In a small trial across ten U.S. research sites, a novel HIV vaccine candidate has shown a result that has eluded scientists ...

A potential breakthrough in the ongoing AIDS crisis could be deprioritized due to the decisions of noted vaccine skeptic Robert F. Kennedy, Jr.

Several vaccines for HIV have been tested in animal studies and an early safety trial in people, showing promising results in both.

Led by a team of African researchers, first doses of the novel T cell-inducing GRAdHIVNE1 vaccine candidate have been given.

The results suggest the possibility of a vaccine for HIV/AIDS, which killed more than half a million people last year.

We may be a step closer to a highly effective mRNA vaccine against HIV, but tests so far reveal that the approach can cause ...

NPR A promising new HIV vaccine was set to start trials. Then came Trump's latest cuts On May 30, a team of researchers funded by the National Institutes of Health got the word: Funding for their ...

The Phase IIa trial verified the safety of the HIV vaccine and its ability to trigger an effective immune response in the ...

The Trump administration's plan to cut funding for HIV vaccine research comes at a time when the field is making substantial progress. Many effective treatments are available for HIV, but these ...

Kenya is one of nine African countries selected for the initial rollout of lenacapavir (LEN), a new injectable drug for human ...

HHS' decision "could stagnate research that has the potential to save millions of lives," writes Simon Williams.

Although the COVID vaccine does not contain gp145, Dr Krawczyk said it was wrong to suggest it could in any way lead to HIV, regardless. "It is great as an antigen to induce immunity after vaccination ...